Biomarkers and translational research and precision medicine

34P - Comparison of HER2, estrogen and progesterone receptor expression profiles of primary tumor and synchronous axillary lymph node metastases in 159 breast cancer patients - indicating tumoral heterogeneity

Authors
  • Laura Weydandt (Leipzig, Germany)
  • Lars-Christian Horn (Leipzig, Germany)
  • Bahriye Aktas (Leipzig, Germany)
Speakers
  • Laura Weydandt (Leipzig, Germany)

Previous ePoster
33P - Germline PALB2 heterozygous mutations in breast cancers: Haploinsufficiency paradigm

Next ePosters
35P - Downregulation of immune checkpoints by doxorubicin and carboplatin-containing neoadjuvant regimens in breast cancer: A new insight into the mechanism of induction of antitumor immunity
No ePoster preview available
36P - Endocrine implications in male breast cancer in Bulgaria
38P - Defining the physiological miRNA landscape in nipple aspirate fluid
40P - WNT, Hedgehog and NOTCH signaling pathways in triple negative breast cancer with high and low content of cancer stem cells
42P_PR - Painting the global picture of HER2-testing for breast cancer. The ONCOLLEGE-001 survey study
43P - CIP2A as a novel target to combat basal like breast cancer
46P - BRCA mutations among triple negative breast cancer without family history of breast and ovarian cancer: The Modena family cancer clinic experience
49P - The metastatic potential of grade I breast carcinoma of no special type: A deep insight into putative molecular mechanisms
50P - ER pathway activity score as a predictive biomarker to improve stratification for neoadjuvant endocrine therapy
51P - Higher ER load is not associated with better outcome in stage I-III breast cancer